// App-Quantinova.ai

: BMP4 Gene Therapy Inhibits Myeloma Tumor Growth, but Has a Negative Impact on Bone

Researchers

Presenter

  • Toril Holien

Principal Investigators

  • Marita Westhrin

  • Siv Helen Moen

  • Muhammad Zahoor

  • Glenn Buene

  • Berit Strdal

  • Hanne Hella

  • Huipin Yuan

  • Joost D de Bruijn

  • Anton Martens

  • Richard WJ Groen

  • Fatima Bosch

  • Ulf Smith

  • Anders Sundan

  • Therese Standal

Medical Centers

  • Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

  • Dept. of Rheumatology, St. Olavs Hospital, Trondheim, Norway

  • Centre or Molecular Inflammation Research CEMIR, Norwegian University of Science and Technology NTNU, Trondheim, Sor-Trondelag, Norway

  • Kuros Biosciences BV, Bilthoven, Netherlands

  • The School of Engineering and Materials Science, Queen Mary University of London, London, United Kingdom

  • Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands

  • Center of Animal Biotechnology and Gene Therapy and Department of Biochemistry and Molecular Biology, School of Veterinary Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

  • Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Ciberdem, Madrid, Spain

  • Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg, Sweden

Locations

  • Norway

  • Netherlands

  • United Kingdom

  • Spain

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Mesenchymal stem cells

  • Serpin A1

Drug/Treatment

  • Interleukin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A